Company Info
Phone(617) 401-9000
Year Established
2013
Ticker
EDIT
Exchange
NASDAQ
Contacts
Gilmore O'NeillPresident & CEO
Damien Grierson
General Counsel
Amy Parison
CFO
Bruce E. Eaton, Ph.D.
CBO & CTO
Linda C. Burkly, Ph.D.
CSO
Jessica Hopfield, Ph.D.
Chair
Caren Deardorf
CCO
Company Description
Editas Medicine, formerly Gengine, is a leading genome editing company focused on translating the power and potential of the CRISPR/Cas9 and CRISPR/Cas12a genome editing systems into a robust pipeline of medicines for people living with serious diseases around the world.
